Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;80(1):151-153.
doi: 10.1053/j.ajkd.2022.03.002. Epub 2022 Apr 1.

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis

Caroline M Hsu  1 , Eduardo K Lacson  2 , Harold J Manley  3 , Gideon N Aweh  3 , Dana Miskulin  4 , Doug Johnson  3 , Daniel E Weiner  4
Affiliations

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis

Caroline M Hsu et al. Am J Kidney Dis. 2022 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Max Pre and Last Pre titers compared to First Post titer for (A) all patients; (B) patients without history of COVID-19, defined by a negative baseline and no COVID-19 prior to the initial vaccine series; and (C) patients with history of COVID-19, defined by a positive baseline or COVID-19 prior to the initial vaccine series. Red cells indicate decrease in stratum after versus before third vaccine dose. Green cells indicate increase in stratum after versus before third vaccine dose. Positive baseline defined as anti-spike IgG titer >1 before or ≤10 days after first dose of vaccine (representing likely prior COVID-19, which may or may not have been diagnosed). Prior COVID-19 was defined as positive SARS-CoV-2 test before full immunity (at 14 days after completion of initial vaccine series).
See this image and copyright information in PMC

References

    1. Media Statement from CDC Director Rochelle P. Walensky, MD, MPH, on Signing the Advisory Committee on Immunization Practices’ Recommendation for an Additional Dose of an MRNA COVID-19 Vaccine in Moderately to Severely Immunocompromised People. Centers for Disease Control and Prevention; 2021. https://www.cdc.gov/media/releases/2021/s0813-additional-mRNA-mrna-dose....
    1. Steiger S., Rossaint J., Zarbock A., Anders H.J. Secondary immunodeficiency related to kidney disease (SIDKD)-definition, unmet need, and mechanisms. J Am Soc Nephrol. 2022;33(2):259–278. - PMC - PubMed
    1. Hsu C.M., Weiner D.E., Aweh G., et al. COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider. Am J Kidney Dis. 2021;77(5):748–756.e1. - PMC - PubMed
    1. Hsu C.M., Weiner D.E., Aweh G.N., et al. Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients. Am J Kidney Dis. 2022;79(2):307–310. - PMC - PubMed
    1. Irsara C., Egger A.E., Prokop W., et al. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers. Clinical Chemistry and Laboratory Medicine (CCLM) 2021;59(8):1453–1462. doi: 10.1515/cclm-2021-0214. - DOI - PubMed

Publication types